2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants

Full Article URL: <a target="_blank" href="https://jamanetwork.com/journals/jama/fullarticle/2841663">https://jamanetwork.com/journals/jama/fullarticle/2841663
Textarea URL (this page): <a href="https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKQZL6KeV5uQkFpVkJuek6htZmBiamRkDAHYOFKQ=_2025-12-16">https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKQZL6KeV5uQkFpVkJuek6htZmBiamRkDAHYOFKQ=_2025-12-16
Source: https://jamanetwork.com/rss/site_3/67.xml
Jamanetwork.com: https://jamanetwork.com
Publication date: 2025-12-16 00:00:00
Last retrieval: 2025-12-20 06:45:59.112583

00:00 - 16 Dec 2025

The 2024-2025 COVID-19 vaccines effectively protected against SARS-CoV-2 infection and emergency department visits, hospitalizations, and deaths during the circulation of JN.1 subvariants, new research finds.